Diversify Advisory Services LLC Acquires Shares of 12,983 Kenvue Inc. (NYSE:KVUE)

Diversify Advisory Services LLC purchased a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 12,983 shares of the company's stock, valued at approximately $304,000.

Other institutional investors have also recently bought and sold shares of the company. Connor Clark & Lunn Investment Management Ltd. raised its holdings in shares of Kenvue by 5.9% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 20,852 shares of the company's stock valued at $445,000 after purchasing an additional 1,155 shares during the period. Teacher Retirement System of Texas raised its stake in Kenvue by 87.2% during the fourth quarter. Teacher Retirement System of Texas now owns 308,467 shares of the company's stock worth $6,586,000 after buying an additional 143,648 shares during the last quarter. Virtu Financial LLC acquired a new position in shares of Kenvue during the fourth quarter valued at about $1,269,000. Mizuho Securities USA LLC raised its position in Kenvue by 46.3% in the fourth quarter. Mizuho Securities USA LLC now owns 181,712 shares of the company's stock worth $3,880,000 after acquiring an additional 57,524 shares during the period. Finally, Sei Investments Co. raised its position in shares of Kenvue by 1.0% in the fourth quarter. Sei Investments Co. now owns 2,207,060 shares of the company's stock valued at $47,121,000 after purchasing an additional 20,802 shares during the period. Institutional investors own 97.64% of the company's stock.

Kenvue Stock Performance

NYSE KVUE traded down $0.07 during trading on Thursday, hitting $22.48. The company's stock had a trading volume of 1,834,486 shares, compared to its average volume of 17,239,895. Kenvue Inc. has a 52 week low of $18.10 and a 52 week high of $25.17. The firm has a market cap of $43.12 billion, a P/E ratio of 40.88, a price-to-earnings-growth ratio of 3.78 and a beta of 0.83. The firm has a 50 day moving average price of $22.08 and a 200 day moving average price of $22.32. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. The business had revenue of $3.74 billion for the quarter, compared to analyst estimates of $3.69 billion. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. Kenvue's quarterly revenue was down 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.28 EPS. Equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Bank of America lowered their price objective on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Tuesday, July 15th. Redburn Atlantic initiated coverage on shares of Kenvue in a report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price objective for the company. Barclays dropped their target price on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, July 15th. Citigroup reduced their price objective on shares of Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a research report on Tuesday, July 15th. Finally, UBS Group dropped their price objective on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $24.71.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.